Ranbaxy beats, Lupin lags estimates
Ranbaxy Laboratories rose 6.1 per cent on Tuesday, after the pharma major reported a net profit of Rs 478 crore for the quarter ended September 30, which was higher than Street estimates. The pharma major reported a net loss of Rs 454 crore in the corresponding quarter of last fiscal. Lupin, however, lagged estimates as its US and Japan businesses failed to fire.
Other Results Videos
Maruti Suzuki Q3 Results: PAT jumps 33% YoY to Rs 3,207 cr; revenue up 15%
L&T Q3 Results: Net profit rises 16% YoY to Rs 2,947 cr; revenue up 19%
L&T Q3 results Preview: Here's what to expect from infrastructure major
Dr Reddy's Q3 Results: Profit meets estimates, jumps 11% YoY to Rs 1,379 cr; revenue up 7%
ITC Q3 Results: Profit rises 6% YoY to Rs 5,335 cr; co declares Rs 6.25/share dividend
